| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
DE:SAX
Stroeer SE & Co. KGaA
|
Sep 22, 2025 | BUY |
Strong Buy
+51.1% avg upside
14 analysts
|
$56.00
49.00% Upside
|
+6.1% | · |
|
DE:FTK
flatexDEGIRO AG
|
Sep 04, 2025 | BUY |
Strong Buy
+21.3% avg upside
9 analysts
|
$31.50
12.83% Downside
|
+34.1% | · |
|
DE:RAA
Rational
|
Aug 27, 2025 | BUY |
Buy
+20.6% avg upside
23 analysts
|
$750.00
22.57% Upside
|
+1.1% | · |
|
DE:GLJ
GRENKE AG
|
Aug 15, 2025 | BUY |
Buy
+281.9% avg upside
10 analysts
|
$21.00
73.87% Upside
|
-34.8% | · |
|
DE:GFT
GFT Technologies
|
Jul 28, 2025 | BUY |
Strong Buy
+37.7% avg upside
6 analysts
|
$30.00
16.23% Upside
|
+34.2% | · |
|
DE:FNTN
freenet
|
Jul 01, 2025 | BUY |
Buy
+5.7% avg upside
19 analysts
|
$34.00
39.39% Upside
|
-9.3% | · |
|
DE:HAG
HENSOLDT AG
|
Jun 19, 2025 | BUY |
Strong Buy
+14.4% avg upside
13 analysts
|
$106.00
33.01% Upside
|
-22.9% | · |
|
DE:RHM
Rheinmetall
|
May 12, 2025 | BUY |
Strong Buy
+28.9% avg upside
30 analysts
|
$2200.00
112.78% Upside
|
-29.2% | · |
|
DE:HYQ
HYPOPORT
|
Jan 21, 2025 | BUY |
Strong Buy
+207.8% avg upside
7 analysts
|
$230.00
171.71% Upside
|
-47.9% | · |
|
DE:COP
CompuGroup Medical
|
Dec 04, 2024 | SELL |
Buy
+56.1% avg upside
12 analysts
|
$10.00
64.80% Downside
|
· | · |
|
DE:NEM
Nemetschek
|
Oct 22, 2024 | HOLD |
Buy
+37.9% avg upside
23 analysts
|
$90.00
42.33% Upside
|
+2.9% | · |
|
DE:FIE
Fielmann
|
Feb 24, 2023 | SELL |
Buy
+54.3% avg upside
10 analysts
|
$25.00
35.59% Downside
|
-32.0% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.